Original contributionMethods of monitoring menstrual function in field studies: Efficacy of methods
References (41)
- et al.
NIOSH selection of chemicals and study publications: setting priorities for reproductive research
Reprod Toxicol
(1988) Monitoring of ovulation in the assessment of reproductive hazards in the workplace
Reprod Toxicol
(1988)Female reproductive toxicology: the time is now
Reprod Toxicol
(1990)- et al.
Methods to monitor menstrual function in field studies: attitudes of working women
Reprod Toxicol
(1992) - et al.
Prediction of ovulation with the use of oral and vaginal electrical measurements during treatment with clomiphene citrate
Fertil Steril
(1987) - et al.
Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle
Am J Obstet Gynecol
(1980) A microcolorimetric determination of creatinine in urine by the Jaffe reaction
J Biol Chem
(1954)- et al.
A comparison of methods to interpret the basal body temperature graph
Fertil Steril
(1983) - et al.
Urinary hormone levels at the time of ovulation and implantation
Fertil Steril
(1985) - et al.
Endocrine profiles and fertility status of human menstrual cycles of varying follicular phase length
Fertil Steril
(1981)
Detection of the ovulatory luteinizing hormone (LH) surge with a semiquantitative urinary LH assay
Fertil Steril
Metabolic fate of human choriogonadotropin
J Steroid Biochem
Luteal phase salivary progesterone concentrations in ovulation-induced cycles
Fertil Steril
Monitoring techniques to predict and detect ovulation
Fertil Steril
Prediction of ovulation
Fertil Steril
Follicle size by ultrasound versus cervical mucus quality: normal and abnormal patterns in spontaneous cycles
Fertil Steril
Occupational exposures associated with male reproductive dysfunction
Annu Rev Pharmacol Toxicol
Agents in the workplace and effects on reproduction
Occupational Medicine: State of the Art Reviews
Cited by (52)
Rationale and study design of an intervention of increased energy intake in women with exercise-associated menstrual disturbances to improve menstrual function and bone health: The REFUEL study
2019, Contemporary Clinical Trials CommunicationsCitation Excerpt :Ovulation was confirmed by presence of a urinary LH peak preceded by an E1G peak. Specific hormonal criteria for E1G, PdG, and LH are identified in Table 1 [8,10,31,53,54]. Participants were also assigned an “overall menstrual status” which incorporated both the self-reported “screening menstrual status” and the hormonal profile “baseline menstrual status.”
Body composition and reproductive function exert unique influences on indices of bone health in exercising women
2013, BoneCitation Excerpt :Ovulatory status was determined by day of the urinary LH surge, identified as an LH peak on the day of or after the midcycle E1G peak [26]. Specific hormonal criteria for detecting ovulation included a LH surge concentration above 25 mIU/mL, the E1G peak concentration above 35 ng/mL, and the peak PdG concentration above 5 µg/mL during the luteal phase [4,27,28]. Total body weight was measured by a digital scale in the laboratory, and height was measured without shoes.
Reproductive Hazards of Occupational and Environmental Exposures
2013, Women and HealthReproductive Hazards of Occupational and Environmental Exposures
2012, Women and Health, Second EditionEstrogen and peptide YY are associated with bone mineral density in premenopausal exercising women
2011, BoneCitation Excerpt :Ovulatory status was determined by urinary LH, identified as a LH peak after the midcycle E1G peak [1,2]. Specific hormonal criteria for detecting ovulation included an LH peak concentration above 25 mIU/mL, the E1G peak concentration above 35 ng/mL, and the peak PdG concentration above 5 μg/mL during the luteal phase [1,2,31,32]. An anovulatory cycle was defined as one of the following: 1) a cycle in which a minimal increase in E1G was observed concomitantly with a failure of LH to rise at midcycle, 2) when PdG concentration failed to increase during the luteal phase from a 5-day follicular phase baseline, or 3) when the peak PdG value was below 2.49 μg/mL [1,2,31].